2022 American Transplant Congress Archives - Page 17 of 190

Can dd-cf DNA Eliminate Unnecessary Biopsies? The Answer is Yes!

K. Andreoni, Y. Chalicheemala, M. Debroy, M. Maklad, K. Zhao, M. Aeder, A. Jittirat, D. Ecabert, A. Bixby, C. Burrelli, K. Chavin
Can Fibroscan Evaluation Of A Liver Predict Transplantability As Accurately As A Biopsy?

S. J. Sander¹, M. Moncure²
Can We Predict Progression of Potential Donation After Cardiac Death Donors (DCD) Using DonorNet?

Y. Bababekov¹, A. Yule¹, H. Moore¹, R. Choudhury², C. Hertert³, T. Pshak⁴, T. Nydam⁵, B. Kaplan¹, E. Pomfret¹, J. Pomposelli⁵
Cardiac Catheterization in ESKD Patients with High Cardiovascular Risk Prior to Kidney Transplantation

L. Morena¹, A. Al Jurdi², M. S. Bittencourt³, A. C. Bucay², N. Elias¹, R. Palsson², L. V. Riella¹
Cardiomyocyte Cross-Sectional Area Increases After Orthotopic Cardiac Xenotransplantation and is Not Likely a Significant Contributor to Xenograft Growth up to 9 Months

C. E. Goerlich¹, B. Griffith¹, J. Treffalls¹, P. Hanna², S. N. Hong², A. K. Singh¹, D. Ayares³, M. Mohiuddin¹
Cardiovascular Assessment After Kidney Transplantation in Children and Adolescents

J. Liu, L. Zhang, X. Li, L. Zhu, Y. Lin, X. He, L. Liu, J. Li, C. Wang, S. Li
Cardiovascular Outcomes of Kidney Transplant Recipients Receiving Belatacept Compared to a Matched Tacrolimus

Y. Kim¹, J. Marvin¹, K. Belfield¹, G. Girone¹, R. Formica², E. Cohen¹
Case Times For Brain Dead Donors: Longer Is Not Better, No Impact Of Longer Case Time On Organ Yield Or OPO Performance Tier

M. J. Moritz¹, R. Hasz¹, H. Nathan¹, E. Hunt², S. Noreen³, A. Toll⁴
Case-Control Study of Belatacept as Maintenance Immunosuppression in Kidney Transplant Recipients Living with HIV

M. Tucker, C. Foppiano Palacios, E. Cohen, S. Virmani, P. Trubin, L. A-Barakat, M. M. Azar, M. Malinis
Causal Factors and Clinical Impact of Urinary Tract Infections in Renal Transplanted Patients: An Observational Retrospective Study

C. Alfieri, F. Tripodi, D. Cresseri, M. Gandolfo, M. Campise, A. Regalia, P. Messa, G. Castellano
CCR2 Antagonism Blocks Microbiota Pro-Inflammatory Effects on Lymph Node Architecture

S. J. Gavzy¹, R. Lakhan², J. Iyyathurai², V. Saxena², Z. L. Lee², B. Ma², E. Mongodin², J. S. Bromberg²
Cd137 on Host Dendritic Cells Fine-Tunes the Intesity of Donor T Cells in Systemic Alloinmmune Responses

S. Park¹, H. Cho², B. Kwon³, J. Lee⁴, H. Park¹, J. Park⁴, K. Park⁴, K. Yoo⁴
CD14⁺ Monocytes Play a Critical Role in Initiating Xeno-Recognition, Costimulation and Immune-Responses to Porcine Endothelial Cells

H. Xu, A. Kirk, H. Xu
CD209+ Macrophages-Mediated Immunosuppressive Effects in ADPKD Tissues

Z. Ou¹, Y. Wang¹, Z. Yan¹, Y. Liu¹, Q. Li¹, Y. Fang¹, J. Geng¹, W. Deng¹, Z. Li¹, R. Xia¹, W. Zeng¹, J. Xu¹, C. Wu², Y. Miao¹
CD31⁺ Extracellular Vesicles in Ex Vivo Lung Perfusion Are Associated with Unsuitability for Transplant

G. C. Madu¹, S. Moshkelgosha², A. Chruscinski³, A. Sage², M. Cypel², S. Keshavjee², S. Juvet²
CD38 Knockout Mice Demonstrate Decreased Neutrophil Infiltration Following Renal Ischemia Reperfusion Injury

I. Woelfel¹, A. Ruffing¹, I. El-Ayachi¹, K. Washburn², S. Black¹, A. Schenk¹
CD40 Expressed by FRC Regulates Lymph Node Structure and Function

M. W. Shirkey¹, L. Li¹, R. Abdi², J. S. Bromberg¹
Cd47 Expression on Transplanted Human Neonatal Mesenchymal Stem Cells Inhibits Phagocytosis in Rat Myocardial Infarction Model

M. Gunasekaran, R. Mishra, S. Sharma, P. Saha, L. Chen, S. Guru, A. Stefanowicz, A. Bilewska, S. Zarinebaf, G. Zhi-Dong, S. Kaushal
CD8⁺ T Cells Differentiate into a CD43-expressing Effector Population After Transplantation

G. Cohen, M. A. Kallarakal, S. M. Krummey
Cd80 on Effector T Cell Binds Pd-l1 on Lymphatic Endothelial Cells to Fine Tune Migration

W. Piao¹, V. Saxena¹, L. Li¹, K. Hippen², Y. Zhang², B. Blazar², I. Lape³, L. Riella³, J. Bromberg¹
cDC1-Mediated Prolongation of Cardiac Allograft Survival and Alloantigen Induced Transcriptional Programming

S. L. Schroth, E. B. Thorp
CEACAM1 Splice Isoforms Are Regulated by Hypoxia Inducible Factors 1 alpha (HIF-1a) to Protect Against Ischemic Injury in Mouse and Human Liver Transplantation

K. J. Dery¹, H. Kojima¹, K. Kadono², H. Hirao¹, J. Kupiec-Weglinski³
Cell-free Amniotic Fluid Reduces Liver Inflammation And Fibrosis

F. Ditmars¹, C. Bowen¹, N. Liu¹, K. L. Pereira de Castro¹, J. Johnson¹, M. Kueht¹, A. Saad², H. L. Stevenson³, J. Fair¹, W. S. Fagg¹
Cell-Free DNA Concentration in Hypothermic Machine Perfusate is a Potential Rapid Marker for Kidney Graft Quality

S. Duarte¹, M. Willman¹, V. Boominathan¹, D. Lewis¹, W. De Faria¹, G. Vrakas¹, A. El-Hinnawi¹, T. Beduschi¹, N. Battula², A. Zarrinpar¹
Center Variation is the Major Driver of Geographic Disparities in Access to Kidney Transplants Among Waitlisted Candidates

D. Stewart, A. Robinson, A. Wilk, D. Klassen
Center Volume and Transplant Outcomes in Adult Kidney Transplant Recipients; A Competing Risk Analysis

A. Azhar¹, E. Defor¹, L. Kamal¹, D. Bandyopadhyay¹, B. Tanriover², G. Gupta¹
Center-Level Variability in DDLT Rate Before and After the Implementation of MMaT/250 Score

T. Ishaque, J. Beckett, B. King, J. G. Wang, D. Segev, A. Massie
Center-Level Variation in Transplantation Practice Following Acuity Circles Policy Change

A. Burton¹, D. Goldberg²
Changes in Cold Ischemia Time and Transplantation Practices with the Concentric Model of Kidney Allocation

C. M. Puttarajappa¹, P. Sood¹, A. Tevar¹, V. Gunabushanam¹, S. Hariharan¹, S. Mohan²
Changes in Diastolic Function and Cardiac Geometry After Pediatric Kidney Transplant: A Longitudinal Study

K. Sgambat¹, S. Clauss², A. Moudgil¹
Changes in Health Equity Under Liver Acuity Circles Allocation

S. Noreen, J. Foutz, A. Henderson, D. Stewart
Changes Of Socioeconomic Status Of Kidney Transplant Recipients And Their Association With Prognosis

S. Park¹, J. Park¹, J. Jihoon¹, Y. Kim¹, Y. Kim², H. Lee²
Characterisation of Kidney-Specific Extracellular Vesicles During Isolated Organ Normothermic Machine Perfusion

J. Ashcroft¹, T. L. Williams², T. R. Elliott¹, A. Marton¹, S. A. Hosgood¹, M. L. Nicholson¹, V. Kosmoliaptsis¹
Characteristics and Outcomes of Anhepatic Patients Listed for Liver Retransplantation

R. G. Kathawate¹, T. Ibeabuchi², P. Abt², T. Bittermann²
Characteristics and Outcomes of Patients Admitted for Acute Alcoholic Hepatitis Before and During the COVID-19 Pandemic

M. S. Anderson¹, S. Uttal², M. Bertha³, K. Jencks², H. Asefah², A. Gustafson³, K. N. Truitt³, P. Maddur³, J. Mellinger²
Characteristics of OPOs with Increased Education Spending, 2013-2018

J. Roberts¹, J. L. Bragg-Gresham², T. Peters³, F. McCormick⁴
Characterization of Activated Islet Proliferating Cells (AIPCs) During Maturation to Pseudo-Islets

Y. Garciafigueroa, J. B. Pollett, N. Thai, R. Bottino
Characterization of Acute Kidney Injury in Fatty Liver Ischemia Reperfusion Injury

Z. P. Rokop, W. Zhang, N. Ghosh, A. Das, N. Biswas, C. Sen, C. Kubal
Characterization of GZMB+ Bregs Transcriptome and Their Impact on Target Cells in Single-Cell RNA-seq

N. Sailliet, H. Le Mai, A. Dupuy, F. Cynthia, M. Chesneau, J. Poschmann, R. Danger, S. Brouard
Characterization Of Gzmb+ Bregs Using Single Cell Rnaseq

N. Sailliet, H. Le Mai, A. Dupuy, C. Fourgeux, M. Chesneau, J. Poschmann, R. Danger, S. Brouard
Characterization of Hepatocytes During Cold Static Preservation at Single Cell Resolution

S. Naik¹, M. Dogan¹, C. Watkins¹, A. Bajwa¹, C. Eymard², J. Eason³, C. Kuscu¹, C. Kuscu¹
Characterization of ICU Delirium Among Liver Transplant Recipients

J. M. Ruck, K. Neufeld, E. Oh, J. C. Lai, E. King
Characterization of Kidney Allograft Pathology Using the Histomap Gene Expression Profile (GEP) and Formalin Fixed Paraffin Embedded (FFPE) Tissue

N. Garg¹, K. Degner², H. Zhang³, W. Tian³, F. Aziz⁴, S. Parajuli², W. Zhong², N. Wilson², S. Panzer¹, A. Djamali²
Characterization Of Local Antibody Responses In Human Cardiac Allograft Vasculopathy

S. B. See¹, L. J. Stanton¹, P. Roy¹, S. Mashiko¹, E. R. Vasilescu², C. C. Marboe², M. Szabolcs², M. V. Habal³, M. Farr³, S. Restaino³, Y. Naka⁴, D. M. Mancini⁵, J. C. Madsen⁶, R. G. King⁷, E. P. Kransdorf⁸, E. Zorn¹
Characterizing Outcomes of Patients with Colorectal Liver Metastases (CRLM) Undergoing Liver Transplantation (LT) Evaluation

E. Takoushian¹, E. Brandon¹, B. Samstein², K. Halazun²
Characterizing the Landscape of Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

J. D. Motter¹, K. Jackson¹, K. Yu², R. M. Pfeiffer², A. Massie¹, J. Garonzik-Wang³, D. Segev¹, E. A. Engels²
Chimeric Antigen Receptor Regulatory T Cells (CAR-Tregs) Provide Significantly Greater Modulation of Alloimmune Responses Than Alternative Alloantigen-Specific Treg Strategies

A. S. Kurt¹, P. Ruiz¹, E. Kodela¹, G. Lombardi¹, M. Martinez-Llordella², A. Sanchez-Fueyo¹
Chronic Active Antibody Mediated Rejection: 3 Month Response Rates to Treatment and Predictors of Graft Survival

F. Aziz, M. Jorgenson, S. Parajuli, N. Garg, V. Manchala, E. Yousif, D. Mandelbrot, L. Hidalgo, M. Mohamed, W. Zhong, A. Djamali
Chronic Ethanol Exposure Prolongs Murine Allograft Survival

D. Swift, M. Ford, W. Kitchens
CIAT: A New Kidney Exchange Program with Better Options for Highly Sensitized and Long Waiting Patients

M. d. Klerk¹, J. Kal¹, D. L. Roelen², M. Betjes¹, A. Weerd de¹, M. Reinders¹, M. Kho¹, K. Glorie³, J. I. Roodnat¹
Circulating and Intragraft Donor (HLA)-Specific B Cells Drive Allograft Rejection After Kidney Transplantation

A. Torija¹, N. Bolaños¹, L. Donadeu¹, M. Meneghini², I. Torres², A. Gabaldon², M. Gomà³, E. Crespo¹, F. Moreso⁴, O. Bestard²
Circulating Antibodies in CMV Viremia in Kidney Transplantation

T. Sigdel¹, P. Velpurisiva¹, V. Dharnidharka², M. M. Sarwal¹
Circulating Donor-Derived Cell-Free DNA: A Novel Non-Invasive Biomarker for Immune Surveillance in Vascularized Composite Allotransplantation

W. J. Rifkin¹, J. Trilles¹, P. S. Rabbani¹, O. C. Onuh¹, B. E. Gelb², D. J. Ceradini¹, E. D. Rodriguez¹
Circulating Galectin-3 Levels Increase in Syngeneic Rat Recipients of Vascularized Composite Allografts Subjected to Prolonged Ischemia

Z. Wang¹, B. Li¹, Y. Wang¹, D. Yoeli¹, N. Nakra¹, N. Limon De La Rosa¹, A. A. Su¹, A. Jani¹, D. W. Mathes¹, K. M. Washington¹, E. Farkash², C. A. Huang¹
Circulating Plasma Proteomics Analysis of CMV Infection in Kidney Transplantation

T. Sigdel¹, P. Boada¹, D. Gjertson², M. Rossetti², B. Fatou³, H. Steen³, J. Schaenman², S. Bunnapradist², E. Reed², M. Sarwal¹
Circumstances Influencing Likelihood to Become an Organ Donor

L. Clayton¹, K. S. Holland², C. W. Nonterah³
Clazakizumab® (anti-il-6) Desensitization in Highly-HLA Sensitized Patients Awaiting Kidney Transplant (nct03380962): Long-Term Follow Up

A. Vo¹, J. Tang¹, N. Ammerman¹, E. Huang¹, X. Zhang², M. Haas³, A. Peng¹, R. Najjar¹, S. Williamson¹, C. Meyers¹, S. Sethi¹, K. Lim¹, M. Gillespie¹, N. Badash¹, S. Jordan¹
Clear Gender Disparity in Living Donor Kidney Transplants

A. C. Gruessner¹, R. Gruessner²
Clinical Characteristics Of Serologic Non-responders To Covid-19 Booster Vaccination In A Cohort Of Solid Organ Transplant Recipients.

F. N. Zervou¹, K. Khalil¹, T. Lao¹, D. Wood², S. Jonche¹, A. Mattoo¹
Clinical Efficacy of Adjuvant Immunotherapy for Liver Transplant Recipients with Exceeding Japan Criteria of Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells

M. Ohira¹, Y. Imaoka², K. Sato³, K. Imaoka¹, N. Tanimine¹, H. Tahara¹, K. Ide¹, T. Kobayashi¹, Y. Tanaka¹, A. G. Tzakis⁴, S. Nishida⁵, H. Ohdan¹
Clinical Evolution of Patients with De Novo DSA After Kidney Transplantation

C. López del Moral¹, N. Lachmann², S. Hergovits², D. Stauch², A. Akifova³, M. Naik³, B. Osmanodja³, D. Schmidt³, K. Budde³
Clinical Features and Outcomes of Hospitalized Solid Organ Transplant and Hematopoietic Stem Cell Recipients with Sars-CoV-2 Infection in the Midwestern United States: A Multi-Center Retrospective Cohort Study

S. Tanna¹, D. Florescu², A. Majeed³, J. Banzon³, S. Waller⁴, A. Eid⁴, N. Barros Baertl⁵, D. Friedman⁶, K. Mullane⁷, M. Ison⁸
Clinical Impact of a Modified Lung Allocation Score That Mitigates Selection Bias

E. M. Schnellinger¹, E. Cantu², D. E. Schaubel¹, S. E. Kimmel³, A. J. Stephens-Shields¹
Clinical Implications of Robotically Assisted Laparoscopic Donor Nephrectomy: A Single Center Experience

A. Popovic¹, S. Loerzel², M. Hanlon², S. Iskhagi², B. Gallay³, E. Shaban³, J. Leggat³, R. H. Dvorai⁴, S. Narsipur⁵, R. Saidi², R. Shahbazov²
Clinical Outcomes In A Large Transplant Cohort Hospitalized With COVID-19: Mycophenolate Mofetil (MMF) Utilization And Mortality Trends

R. L. Gottlieb¹, M. Askar², L. Chen³, A. Chandak⁴, E. Mozaffari³, M. Thrun³, R. Haubrich³
Clinical Outcomes of Solid Organ Transplant (SOT) Patients with Epstein-Barr Virus-Driven (EBV⁺) Post-Transplant Lymphoproliferative Disease (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study

V. Dharnidharka¹, D. Thirumalai², U. Jaeger³, W. Zhao², D. Dierickx⁴, P. Xun², P. Minga⁵, A. Sawas⁶, N. Sadetsky⁷, P. Chauvet⁸, E. Sundaram⁹, A. Barlev⁷, H. Zimmermann¹⁰, R. U. Trappe¹⁰
Clinical Outcomes with IR-tac to LCP-tac Conversion in a Kidney Transplant Population

F. Bartlett¹, J. Newman¹, T. Sprague¹, S. Patel¹, N. Rao², E. Andrade², V. Rohan², M. Casey², D. Dubay¹, D. Taber¹
Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients with Biopsy Proven BK Polyomavirus Associated Nephropathy

H. Omic¹, J. P. Kläger¹, H. Herkner¹, S. W. Aberle¹, H. Regele¹, L. Weseslindtner¹, T. A. Schrag¹, G. Bond¹, K. Hohenstein¹, B. Watschinger¹, J. Werzowa², R. Strassl¹, M. Eder¹, Z. Kikic¹
Clinical Relevance of Class II HLA Mismatches in Living Donor Kidney Transplantation

J. Lan¹, M. Kadatz¹, D. Chang¹, R. Liwski², E. Wagner², P. Campbell², J. Gill¹, J. Gill¹
Clinical Significance of Chronic Active T-cell Mediated Rejection in Renal Transplant Biopsies

C. T. Chung¹, A. Han², H. Kim³, S. Min², J. Ha²
Clinical Significance of Delayed Graft Function and Slow Graft Function in Living Donor Kidney Transplantation

J. Song¹, S. Jeong¹, S. Min¹, J. Ha¹, J. Lee², J. Jeong³, Y. Kim¹, Y. Kim¹, H. Lee¹
Clinical Significance of the Living Kidney Donor Profile Index in Living Kidney Donors for Predicting of Post-Transplant Outcome: Korean Organ Transplantation Registry

J. Kim¹, D. Kim¹, S. Yoon¹, S. Kang¹, J. Kim¹, H. Hwang¹, K. Jeong¹, H. Ko², C. Jung³, D. Kim⁴, Y. Kim⁵, J. Yang⁶, C. Ahn⁷
Clinical Significances Of Anti-collagen Type I And Type Iii Antibodies In Antibody-mediated Rejection

S. Park¹, S. Yang¹, K. Moon¹, J. Ha¹, Y. Kim¹, E. Song¹, H. Lee²
Clinical Stratification of Pediatric Liver Transplant Recipients 4-5 Years Post-Transplant: 1^St Step Towards Personalized Management

W. Dixon¹, E. R. Perito¹, M. Tavakol¹, J. Bucuvalas², S. Feng¹
Clinical Use of the SIPAT Score in a Large Heart Transplant Program

S. Kim, M. Kittleson, J. Patel, N. Patel, T. Singer-Englar, D. Chang, E. Kransdorf, A. Huynh, L. Olanisa, M. Olman, J. A. Kobashigawa
Clinical Utility of Donor-Derived Cell-Free DNA During the Period of Recovery of Renal Function After Kidney Transplantation

Y. C. Dreige¹, G. Bittencourt Pereira Lima¹, M. Cristelli¹, M. Nakamura¹, R. D. Foresto¹, P. Pierry¹, R. Ponsirenas², J. Levi¹, J. Medina¹, H. Tedesco¹
Clinical Validation of Automated Urinary Chemokine Assays for Non-Invasive Detection of Kidney Transplant Rejection: A Large Prospective Cohort Study

E. Van Loon¹, C. Tinel¹, J. Callemeyn¹, M. Coemans¹, A. Van Craenenbroeck¹, T. Vaulet², D. Anglicheau³, M. Naesens¹
Clinically Available Immunosuppressive Agents Prolong Pig-to-Primate Kidney Xenograft Survival

I. J. Anwar¹, Q. Gao¹, I. DeLaura¹, J. Yoon¹, R. Baldi¹, M. Youd², K. Stiede², K. Hall², S. Knechtle¹, J. Kwun¹
Clusterin Protects Kidney Transplants from Ischemia-Reperfusion Injury by Modulating Neutrophil Infiltration

Y. Shim¹, R. Fan², N. Dvorina², K. McCrae¹, B. William²
CMV Specific T Cell Immune Response in Hepatitis C Negative Kidney Transplant Recipients Receiving Transplant from Hepatitis C Viremic Donors and Hepatitis C Negative Donors

M. Z. Molnar¹, M. Tsujita², M. Talwar², V. Balaraman², A. Bhalla², J. D. Eason², S. S. Nouer², K. Sumida², A. Remport³, I. E. Hall¹, R. Griffin², G. George Rofaiel⁴, A. Azhar⁵
Cmv-Specific Cell-Mediated Immune Reconstitution in High-Risk Hematopoietic Cell Transplant Recipients Receiving Letermovir Prophylaxis

M. Z. Abidi¹, K. Garth¹, J. Gutman², A. Weinberg¹
Co-stimulation Patways Pd-1 (the Programmed Death 1) And Icos (the Inducible T Cell Co-stimulator) In Peripheral Mononuclear Cells Mesured By Flow Cytometry As A Possible Tool In The Follow-up And Diagnosis Of Kidney Transplant Rejection.

M. A. Carmona-Escamilla
Cognitive Bias in Transplant Surgery: A Qualitative Study of Transplant Clinicians in the United States

K. Ladin¹, J. Perry², C. Eiduson³
Cognitive Impairment In Liver Transplant Recipients 6 Months Or More After Transplant

K. Berry¹, L. Gaynor¹, F. Barry¹, E. Tsoy¹, C. Goode¹, R. Wong¹, S. Erlhoff¹, L. VandeVrede¹, K. Possin¹, J. C. Lai²
Cold Ischemia Time is More Critical for Older Donor Kidney Survival: A Machine Learning Approach

J. Kim, J. Ahn, A. Massie, D. Segev, S. Bae
Cold Ischemic Time and Kidney Graft Failure; Mediation Through Delayed Graft Function

J. Miller¹, W. Irish², D. Sawinski³, A. Massie⁴, J. Snyder¹
Cold Pulsatile Perfusion of Deceased Donor Kidneys Substantially Improves Kidney Utilization of Donors After Cardiac Death and Brain Dead Donors with KDPI Greater Than 60%

D. S. Keith, E. Lessmann
Cold Pulsatile Perfusion of Donor Kidneys Varies Significantly by Procuring Organ Procurement Organization Indicating Both Over and Underutilization of This Preservation Method

D. S. Keith, E. Lessmann
Cold Pulsatile Perfusion Preservation of Deceased Donor Kidneys Did Not Improve Delayed Graft Function Rates in Most Transplants Due to Longer Cold Ischemia Times Offsetting Much of the Benefit, Analysis of SRTR Database

D. S. Keith, E. Lessmann
Cold Pulsatile Perfusion Resistance of Deceased Donor Kidneys Mainly Dependent on Renal Mass, Donor Age and Donor AKI, Other Donor Factors Have Minimal Impact

D. Keith, E. Lessmann
Cold Stress-Induced Ferroptosis in Liver Sinusoidal Endothelial Cells Deteriorates Liver Transplant Outcomes

H. Kojima, H. Hirao, K. Kadono, T. Ito, K. J. Dery, F. Kaldas, J. Kupiec-Weglinski
Collaboration for Successful Transition to Adult Care in Liver Transplant: Early Outcomes of a Structured Program with Youth Engagement

B. Kosmach-Park¹, J. Kilpatrick², A. Algeo¹, K. Jones¹, L. Remaley¹, N. Elazzazy², N. Jonassaint³, G. Mazariegos¹
Combined CyTOF and Elispot Investigation of CMV Response Over the First Year Post Kidney Transplantation

T. Jouve¹, L. Donadeu Casassas², S. Hartzell³, E. Crespo², M. Meneghini², A. Torija², P. Cravedi⁴, O. Bestard²
Combined Genome Wide and Single Nuclei Transcriptomics in Posttransplant Acute Kidney Injury Identifies Early Proinflammatory/Profibrogenic Cell Origin

J. McDaniels¹, T. Rousselle¹, E. Bardhi¹, A. Shetty¹, E. Akalin², D. Maluf¹, V. Mas¹
Combined Heart-Liver Transplantation for Failing Fontan Physiology: A Large Single Center Comparative Analysis

C. J. Rosenthal¹, D. Noguchi¹, J. A. Aboulhosn², G. S. Van Arsdell³, A. Nsair⁴, M. Ha¹, L. Reardon², G. Lluri⁴, J. P. Lin⁴, S. Saab¹, A. Baird¹, R. S. Venick¹, D. G. Farmer¹, F. M. Kaldas¹
Combined Metagenomic Viral Detection and Donor-Derived Cell-Free DNA Quantification for Solid Organ Transplant Recipients

R. Sinha¹, C. Rebello², E. Bixler¹, A. Al-Turck¹, A. Berg¹, J. Friedewald², S. Kleiboeker¹
Comparative Analysis of kSORT Assay for Predicting Acute Renal Allograft Rejection Under Belatacept-Based Immunosuppression

H. Hames¹, M. Sarwal², I. Damm², E. Yanqui¹, A. Burg¹, A. Christianson¹, A. R. Shields¹, D. Hildeman¹, R. R. Alloway¹, E. S. Woodle¹
Comparative Analysis of Liver Organ Offers Pre- and Post- Acuity Circle Policy Change in the US

V. Reddy¹, R. Ruiz², H. Fernandez³, J. Bayer³, E. Martinez³, A. Gupta³, G. McKenna⁴, N. Onaca³, S. Lee³, T. Ma³, G. Testa³, A. Wall³
Comparative Case Study of Mycobacterium Infections in Pediatric Post Intestinal Transplant

S. Yerina¹, R. Kanthula¹, Y. Rekhtman², S. Kaufman¹, U. Ekong¹, N. Yazigi¹, T. Fishbein¹, A. Kroemer¹, C. Matsumoto¹, K. Khan¹
Comparative Outcomes at a Single Center for 71 Deceased Donor Kidney Transplants from Donors with Sars-CoV-2 RNA Detection

C. E. Koval¹, E. Poggio², M. Eltemamy³, Y. Lin², M. Duck⁴, N. Shrestha⁵, A. Wee²
Comparing Disparities in Access to First and Re-Kidney Transplantation Among Hispanic and Black Adults in the United States

S. Sandal¹, J. Ahn², V. Thompson³, T. Purnell⁴, M. Cantarovich⁵, D. Segev³, M. McAdams DeMarco³
Comparing Infection Rate Between Steroid Withdrawal and Ongoing Maintenance Among Simultaneous Pancreas-Kidney Transplant Recipients

M. McCord¹, Z. Yetmar², A. Lemke¹, K. Mara³, M. T. Seville⁴, W. Bosch⁵, P. Dean⁶, E. Beam², S. Bernard¹
Comparing Long-Term Outcomes of Steroid-Based versus Steroid-Avoidant Immunosuppression in Pediatric Kidney Transplant Recipients

N. Hayde¹, E. Blanchette², J. Zhang³, M. Chandran², M. Bock², S. Galbiati³, T. Blydt-Hansen⁴
Comparing The Immunologic Responses Between Kidney Transplant Recipients Receiving Standard Immunosuppression And CNI Reduction After Two Doses Of ChAdOx-1 And A Booster Dose BNT162b2

S. Phirom¹, T. Kitrungphaiboon², W. Jantarabenjakul², Y. Avihingsanon², W. Prasithsirikul³, J. Vanichanan⁴, P. Hansasuta⁵, N. Townamchai⁶
Comparison of Cardiovascular Events by Different Types of Lipid-Lowering Drugs in Kidney Transplant Recipients

S. Bae¹, J. Ahn², M. A. Schnitzler³, K. Lentine⁴, D. Segev¹, M. McAdams-DeMarco¹
Comparison of Cephalexin and Ciprofloxacin Prophylaxis for Urinary Tract Infection in Kidney Transplant Recipients

N. A. Pauley, M. Fitzmaurice, A. Poparad-Stezar, B. Summers, A. Jantz
Comparison of CT Volumetry versus Nuclear Renography for Predicting Remaining Kidney Function After Uninephrectomy in Living Kidney Donors

S. Eum¹, H. Lee¹, E. Ko¹, H. Cho², H. Yoon³, S. Shin³, C. Yang¹, B. Chung¹
Comparison of IGG and IGM Type B Cell Receptor-Mediated MTOR Phosphorylation Signal

Y. Matsuda
Comparison of Immediate-Release Tacrolimus to Envarsus XR on the Development of Donor Specific Antibodies in Kidney Transplant Recipients

R. A. Arora, C. Kane, K. Lang, M. Kapugi, C. D'Agostino, K. Cunningham, S. H. Park
Comparison of Outcomes and Management of COVID Infection Among Kidney Transplant Recipients Between Pre-Vaccination Rollout Era and Post-Vaccination Rollout Era

G. Uehara¹, K. Soliman², V. Rao², M. Casey², D. Taber³, M. Posadas Salas²
Comparison of Outcomes in High Donation After Circulatory Death Liver Transplantation Usage Centers in the Acuity Circles Era

L. Chau¹, A. Mohamed², T. Kitajima¹, K. Collins³, M. Rizzari¹, A. Yoshida⁴, M. Abouljoud³, S. Nagai¹
Comparison of Outcomes of Covid-19 Between Fully Vaccinated and Unvaccinated Kidney Transplant Recipients and According to the Type of M-RNA Vaccine

F. Villanego¹, M. Crespo², V. Lopez³, S. Zarraga⁴, F. Oppenheimer⁵, L. Llinas², A. Andres⁶, C. Diaz⁷, M. Ruiz⁸, F. Moreso⁹, A. Rodriguez-Benot¹⁰, I. Beneyto¹¹, S. Cabello¹², C. Jimenez¹³, C. Canal¹⁴, M. Molina¹⁵, J. Pascual⁶, A. Mazuecos¹
Comparison of Perioperative Antibiotic Prophylaxis Regimens on Surgical Site Infections in Pancreas Transplant Recipients

Z. A. Yetmar¹, M. McCord², B. Lahr³, A. Lemke², P. G. Dean⁴, Y. C. Kudva⁵, M. T. Seville⁶, W. Bosch⁷, S. A. Bernard², E. Beam¹
Comparison of Statin-Associated Adverse Events Across Different Types of Statins in Kidney Transplant Recipients

S. Bae¹, J. Ahn², M. A. Schnitzler³, K. Lentine⁴, D. Segev¹, M. McAdams-DeMarco¹
Comparison of Vasodilators in Dual Vessel Normothermic Ex Vivo Liver Machine Perfusion of Rat Liver Grafts

J. M. Gassner, F. Strobl, J. Michelotto, K. Kristina, V. Muth, M. Zimmer, L. Gilles, S. Moosburner, J. Pratschke, I. Sauer, N. Raschzok
Complement 5 Regulation Ameliorates Antibody-Mediated Rejection After Liver Transplantation in Rats

T. Tajima¹, K. Hata¹, J. Kusakabe¹, H. Miyauchi¹, X. Zhao¹, S. Kageyama¹, T. Okamoto¹, Y. Wang², E. Hatano¹
Complete and High-Resolution HLA Typing Improves the Accuracy of Post-Transplant Assessment of De Novo Anti-Donor Immune-Mediated Events

M. Meneghini¹, A. Perona², E. Crespo³, F. J. Bemelman⁴, P. M. Reinke⁵, O. Viklicky⁶, M. Giral⁷, O. Bestard¹
Complex Donor Transfer and Organ Procurement Organization Collaboration to Reduce Ischemia Time in Combined Face and Bilateral Hand Transplant

J. Trilles¹, D. Boczar¹, B. F. Chaya¹, Z. P. Berman¹, G. K. Diep¹, R. Rodriguez Colon¹, D. J. Ceradini¹, E. D. Rodriguez¹, B. E. Gelb²
Compliance with OPTN Infectious Disease Testing

L. Irwin
Comprehensive Profiling of Monocytes During Cellular (TCMR) or Mixed Antibody-Mediated Rejection (ABMR) After Kidney Transplantation

C. Macedo¹, E. Bailly¹, K. Louis², X. Gu¹, M. Lucas¹, A. Zeevi¹, P. Randhawa¹, A. Bansal³, D. Metes¹
Computer vs Human-Based Prediction and Stratification of the Risk of Long-Term Kidney Allograft Failure

G. Divard¹, M. Raynaud¹, V. Tataputii², B. Abdalla³, C. Legendre¹, C. Lefaucheur¹, O. Aubert¹, A. Loupy¹
Concordance of Kidney and Pancreas Rejection on Protocol and for Cause Biopsy in Simultaneous Kidney Pancreas Transplantation

P. Budhiraja, R. Heilman, H. Khamash, A. Jaramillo, D. Ramon, H. Me, J. Ninan, S. Reddy, s. S. Misra, H. Chakkera
Concordance of POLQ and PARP-1 Expression and MMEJ Type Viral Integration in the Progression of BKPyV-Associated Diseases

Y. Wang¹, Z. Yan¹, Y. Liu², J. Geng³, W. Deng¹, R. Xia¹, W. Zeng¹, J. Xu¹, C. Wu⁴, Y. Miao¹
Concurrent Use of Two Methods Prevents Erroneous HLA Typing of Deceased Organ Donors – An Essential Strategy for Patient Safety and Accurate Virtual Crossmatching for Broader Sharing

R. Rajalingam, T. dela Cruz, C. Dames, L. Pagaduan, Y. Cho, D. Kong
Consent to Organ Offers from Public Health Service Increased Risk Donors Decreases Time to Transplant and Waitlist Mortality

Y. Kelly, A. Zarinsefat, M. Tavakol, A. Shui, C. Huang, J. P. Roberts
Contacts Between Organ Donor Families and Their Recipients is Therapeutic for Both Sides in Most Cases

R. Green
Contributions of Allogenicity and Antigen Presentation to Regulatory B Cell Suppression

K. Lee, F. Qiang, K. Deng, R. Matheson, J. Lei, C. LeGuern, J. Markmann
Controlling Instability at Reperfusion: Another Benefit of Normothermic Machine Perfusion Using OCS Liver

C. S. Hwang¹, C. Shi², M. Patel¹, J. Shah¹, L. DeGregorio¹, S. Hanish¹, Y. Kadakia³, U. Chaudhary³, E. Okoro², S. Cheruku², P. Lahsaei², P. Vagefi¹, M. MacConmara⁴
Conversion from Immediate to Extended-Release Tacrolimus (LCP-Tac) Six Months After Renal Transplantation Optimizes Safety and Efficacy

S. P. Patel, F. Bartlett, T. Sprague, J. Newman, E. Andrade, N. Rao, N. Patel, D. Dubay, V. Rohan, M. Casey, D. Taber
Conversion of Tacrolimus Immediate Release to LCP Tacrolimus in Obese Kidney Transplant Recipients

J. Newman, N. Patel, S. Patel, T. Sprague, E. Andrade, N. Rao, F. Bartlett, D. DuBay, V. Rohan, M. Casey, D. Taber
Conversion to Belatacept for Calcineurin Inhibitor Toxicities

S. S. Patel, P. Jadav, M. Sekulic, S. Kudose, I. Batal, S. Mohan, R. Crew
Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity

K. Hotta, N. Iwahara, T. Tanabe, N. Shinohara
Coordinated, Multimodal Care After Kidney Transplantation Improves Graft Survival and Cardiovascular Risks – Results of the Kidney Transplantation 360°- Study (ktx360°)

L. Pape¹, M. DeZwaan², V. Kliem³, H. Nolting⁴, J. Wolff⁴, U. Tegtbur⁵, M. Schiffer⁶
Correction of Hyperoxaluria in a Primary Hyperoxaluria Type 2 Patient After Simultaneous Liver Kidney Transplantation

K. Genena, D. Milliner, J. Lieske
Correlating Histology, Immunohistochemical, & Serologic Data in Heart Transplant Recipients: Implications for Molecular Diagnostic Assays

P. Randhawa, Y. Huang
Correlation of Donor-Derived Cell-Free DNA with Histology and Molecular Diagnoses of T-cell Mediated Rejection in Kidney Transplant Biopsies

D. Kumar¹, I. Moinuddin¹, L. Kamal¹, M. Shinbashi¹, N. Raju¹, R. Minniti¹, F. Moran¹, P. Halloran², G. Gupta¹
Correlation of Non-HLA Antibodies and Biopsy-Proven Antibody-Mediated Rejection

N. Patel, M. Kittleson, J. Patel, T. Singer-Englar, S. Kim, D. Chang, E. Kransdorf, D. Megna, J. A. Kobashigawa
Cortex Recipient Weight Ratio is a Predictor for Short-Term Renal Function After Living Donor Kidney Transplant

K. Takahashi¹, K. Furuya¹, J. Usui², T. Kimura³, S. Fukuda⁴, A. Hoshi³, T. Yoshino³, H. Nishiyama³, T. Oda¹, K. Yamagata²
Cost-Effective and Time-Saving Three-Dimensional (3-D) Printing Protocol of Intra-Abdominal Cavity of Liver Transplantation Recipient to Prevent Large-for-Size Syndrome

S. Park, G. Choi, J. Kim, S. Lee, J. Joh, J. Rhu
Cost-Effectiveness of an Intra-Operative Renal Allograft Cooling Device

K. Hansen¹, C. Yock², J. Pietzsch²
Cost-Effectiveness of Transplanting Hepatitis C Donor Hearts Into Hepatitis C Uninfected Recipients

A. R. Gandhi¹, A. E. Woolley², L. R. Baden², M. M. Givertz², M. L. Jones¹, J. Kim³, H. R. Mallidi², M. R. Mehra², A. M. Neilan¹
Costs Associated with Induction Therapy for Pediatric Kidney Transplantation

N. M. Rodig¹, H. Pizzo², D. Levy Erez³, T. Richardson⁴, M. Somers¹
COVID Infection Among Kidney Transplant Recipient During the Era of COVID Vaccination: Management Outcomes

G. Uehara, K. Soliman, V. Rao, M. Casey, D. Taber, M. Posadas Salas
Covid-19 in Pediatric Kidney Transplant: A Follow-Up Report of the Improving Renal Outcomes Collaborative

C. Varnell, L. Harshman, M. Seifert, D. Hooper
COVID-19 in Solid Organ Transplant: A Global Perspective

.. C19TxR Consortium
COVID-19 Infection Post-Transplant: What is the Collateral Damage to the Graft? A Case for Pre-Transplant Vaccination

A. Fabick¹, E. Overly¹, V. Rao², V. Rohan³, N. Patel¹, D. DuBay³, C. Candland³, N. Pilch¹
COVID-19 Syndrome After Liver Transplant: Immunosuppression Role and Risk Factors for Mortality

M. M. Pascale¹, F. Frongillo¹, G. Bianco¹, F. Galiandro², E. Nure¹, S. Agnes¹, F. Giovinazzo¹
COVID-19 Vaccination Induces a Poor Interleukin-21 Memory T-cell Response in Kidney Transplant Recipients

S. R. Malahe¹, Y. den Hartog¹, R. de Kuiper¹, D. Reijerkerk¹, D. Geers², C. H. GeurtsvanKessel², M. M. Kho¹, R. D. de Vries², M. E. Reinders¹, C. C. Baan¹
Covid-19 Vaccination Response In Tacrolimus Treated Kidney Transplant Recipients With And Without Mycophenolate Mofetil: Follow-up Of A Randomized Controlled Trial

Z. Al Fatly¹, M. G. Betjes¹, A. L. Messchendorp², J. S. Sanders², M. E. Reinders¹, M. M. Kho¹, A. E. de Weerd¹
CoVID-19 Vaccine Efficacy in Heart Transplant Recipients, a Single Center Experience

M. Yu¹, S. B. Sharmin², C. Joyce³, Z. Pieters¹, S. DeSirkar¹, M. Thomas¹, S. Kim¹, E. Bruno¹, M. Liebo¹, A. Heroux⁴, N. Clark¹, G. Reid¹, S. Uprichard²
COVID-19+ Kidney Transplant in US Veterans: An Opportunity to Increase Transplant Rates

V. E. Whittaker
Covid-related Neonatal Cholestasis?: Liver Transplantation In Three Infants With Intrauterine Or Perinatal Covid Exposure

S. Sakhuja¹, K. Patel¹, N. T. Galvan²
Covid19 in Pediatric Kidney Transplant Recipients: Incidence, Outcomes, and Response to Vaccine

A. Moudgil, K. Sgambat, Y. Shi, M. Meyers, C. Petyak, L. Midgley
Creating a Workflow for the Electronic Medical Record Allows Living Donor Liver Transplantation Programs to Track Candidates and Identify Areas for Optimization

A. Liapakis¹, R. Batra¹, E. Cohen², D. Haakinson¹, M. Schilsky¹, K. Ventura², D. Mulligan¹
Critical Care of the Brain-Dead Recipient of a Pig-to-Human Renal Transplant

G. L. Piper¹, P. Sommer², J. M. Stern¹, B. Sullivan¹, E. Weldon¹, N. Lawson¹, B. Lonze¹, R. Dieter², G. Boulton¹, R. Montgomery¹
Crosstalk Between micro-RNAs, mRNAs, and Long Non-Coding RNAs in Human Hepatic Ischemia Reperfusion Injury

C. Kuscu¹, S. Naik¹, C. Eymard², A. Bajwa¹, D. Maluf³, V. Mas³, J. Eason⁴, C. Kuscu¹
Cryptococcal Meningitis Presenting as SIADH in a Heart Transplant Recipient

D. Blake, M. Ibrahim, E. Hamad, V. Rakita, J. Hoosain, H. Clauss
CT Based Iliac Vessel Calcification Scoring: Long Term Patient and Allograft Outcomes

L. Clementoni, M. R. Akhtar, C. Seet, M. Saoud, R. Shah, I. H. Mohamed, M. A. Khurram
Current State of Use of Hepatitis C Viremic Donor Organs in Negative Recipients in the United States: A National Survey

K. Ryland¹, K. Hattori², J. Steinbrink³, N. Theodoropoulos⁴, M. Ison⁵
Cutaneous Angiosarcoma in Solid Organ Transplant Recipients – Novel Case & Review of the Literature

S. M. Elzein, R. R. Caplan
Cytomegalovirus Prevention in Kidney and Pancreas Transplant Recipients: A Successful Pharmacist-Led Multidisciplinary Approach

J. Geyston, J. Dann, A. Doyle, A. Agarwal, K. Brayman, C. Shoemaker, C. Lester, S. Rao
Cytomegalovirus Prophylaxis in Pediatric Liver Transplantation: A Comparison of Strategies Across the SPLIT Consortium

E. D. Knackstedt¹, S. G. Anderson², R. Anand², J. Mitchell², J. Bucuvalas³, L. Danziger-Isakov⁴